1. Home
  2. TARA vs AP Comparison

TARA vs AP Comparison

Compare TARA & AP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

N/A

Current Price

$2.76

Market Cap

236.1M

Sector

Health Care

ML Signal

N/A

AP

Ampco-Pittsburgh Corporation

N/A

Current Price

$8.99

Market Cap

240.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
TARA
AP
Founded
N/A
1929
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
236.1M
240.5M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
TARA
AP
Price
$2.76
$8.99
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
★ $25.71
N/A
AVG Volume (30 Days)
★ 740.0K
59.4K
Earning Date
11-09-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.25
N/A
EPS
N/A
★ 0.03
Revenue
$2,948,000.00
★ $434,166,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.52
P/E Ratio
★ N/A
$303.33
Revenue Growth
N/A
★ 3.79
52 Week Low
$3.19
$1.75
52 Week High
$7.82
$12.81

Technical Indicators

Market Signals
Indicator
TARA
AP
Relative Strength Index (RSI) 25.92 57.21
Support Level N/A $8.95
Resistance Level $4.13 $9.13
Average True Range (ATR) 0.22 0.37
MACD -0.06 0.09
Stochastic Oscillator 8.21 84.34

Price Performance

Historical Comparison
TARA
AP

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

About AP Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corp manufactures and sells engineered, high-performance specialty metal products and customized equipment utilized by industry throughout the world. It operates in two business segments, namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, & other metals. The Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, & Buffalo Pumps. The company generates a majority of its revenue from the Forged & Cast Engineered Products segment. It has a business presence in the United States & other countries.

Share on Social Networks: